Ajay Niranjan
Overview
Explore the profile of Ajay Niranjan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
308
Citations
3301
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Singh R, Dayawansa S, Pham D, Mantziaris G, Peker S, Samanci Y, et al.
Radiother Oncol
. 2025 Feb;
206:110795.
PMID: 39983872
Background: There are limited data on dosimetric predictors of radiation-induced changes (RICs) for brainstem metastases or arteriovenous malformations (AVMs) following single-fraction stereotactic radiosurgery (SRS). Methods: We examined a multi-institutional cohort...
2.
Daza-Ovalle A, Bin-Alamer O, Wei Z, Abou-Al-Shaar H, Hadjipanayis C, Gardner P, et al.
Neurosurgery
. 2025 Jan;
PMID: 39878475
Background And Objectives: Jugular paragangliomas (JPG) pose a surgical challenge because of their vascularity and complex location. Stereotactic radiosurgery (SRS) offers a minimally invasive management for patients with JPG. Our...
3.
Gecici N, Habib A, Niranjan A, Balzer J, Sherry N, Zinn P
Neurosurg Focus Video
. 2025 Jan;
12(1):V6.
PMID: 39845306
Intraoperative neuropsychological testing (IONT) is a sophisticated method of cognitive mapping during the resection of brain tumors in eloquent areas. Direct electrical stimulation during awake craniotomy is routinely utilized for...
4.
Langlois A, Iorio-Morin C, Kallos J, Niranjan A, Lunsford L, Peker S, et al.
Neurosurgery
. 2025 Jan;
96(4):870-880.
PMID: 39808548
Background And Objectives: Oligodendrogliomas are primary brain tumors classified as isocitrate deshydrogenase-mutant and 1p19q codeleted in the 2021 World Health Organization Classification of central nervous system tumors. Surgical resection, radiotherapy,...
5.
Bin-Alamer O, Abou-Al-Shaar H, Singh R, Bowden G, Mathieu D, Perlow H, et al.
J Neurosurg
. 2024 Dec;
:1-9.
PMID: 39642356
Objective: This study aimed to evaluate local control (LC) of tumors, patient overall survival (OS), and the safety of stereotactic radiosurgery (SRS) for esophageal cancer brain metastases (EBMs). Methods: This...
6.
Wei Z, Taori S, Mehta M, Jose S, Luy D, Abou-Al-Shaar H, et al.
J Neurosurg
. 2024 Nov;
:1-9.
PMID: 39576970
Objective: The optimal management of neurofibromatosis type 2 (NF2)-associated meningiomas must be personalized case by case. Stereotactic radiosurgery (SRS) is one option for patients with one or multiple intracranial meningiomas...
7.
Long-Term Outcomes of Stereotactic Radiosurgery for Pineocytomas: An International Multicenter Study
Hamel A, Tourigny J, Niranjan A, Lunsford L, Wei Z, Srinivasan P, et al.
Neurosurgery
. 2024 Nov;
PMID: 39508591
Background And Objectives: Pineocytomas are grade 1 tumors arising from the pineal parenchyma. Gross total resection can potentially cure these benign lesions but can be associated with morbidity. This study...
8.
Grogan D, Dumot C, Mantziaris G, Tos S, Tewari A, Dayawansa S, et al.
Neurosurgery
. 2024 Nov;
PMID: 39508579
Background And Objectives: Stereotactic radiosurgery (SRS) represents an effective treatment for nonfunctioning pituitary adenomas (NFPAs). However, no data have yet been published regarding results of SRS on NFPAs after multiple...
9.
Tos S, Hajikarimloo B, Mantziaris G, Shaaban A, Pham D, Dayawansa S, et al.
J Clin Neurosci
. 2024 Oct;
129:110879.
PMID: 39426317
Background: Hemangioblastomas (HBs) are rare, benign central nervous system (CNS) neoplasms that rarely occur in the supratentorial. Resection with the goal of gross total resection (GTR) is often considered the...
10.
Pikis S, Mantziaris G, Protopapa M, Tos S, Kowalchuk R, Ross R, et al.
J Neurooncol
. 2024 Aug;
170(1):199-208.
PMID: 39192068
Purpose: To report patient outcomes and local tumor control rates in a cohort of patients with biopsy-proven HER-2 positive breast cancer treated with stereotactic radiosurgery (SRS) for brain metastases (BM)....